TORONTO, April 09, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“ Satellos ” or the “ Company ”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that it will participate in the Bloom Burton & Co. Healthcare Investor Conference taking place April 21-22, 2026, at the Metro Toronto Convention Centre in Toronto, Canada.
This excerpt is quoted from the original release. Read the full announcement on GlobeNewsWire.
Brief Summary
Satellos Bioscience Inc. is set to present at the upcoming Bloom Burton & Co. Healthcare Investor Conference, which will occur on April 21-22, 2026. This prestigious event brings together leading healthcare professionals and investors, creating a platform for valuable exchange and insights in the biotech sector.
- Company Name: Satellos Bioscience Inc.
- Event: Bloom Burton & Co. Healthcare Investor Conference
- Dates: April 21-22, 2026
- Location: Metro Toronto Convention Centre
- Focus: Degenerative muscle diseases
Why it matters: Participation in this conference underscores Satellos’ commitment to advancing innovative treatments and engaging with investors about its progress and vision.
Read the Full Article
This is a summary of the press release. For the complete article and any additional details, please visit the original source.
Attribution: Original press release by GlobeNewsWire on . We provide an AI-generated summary and links for convenience. Always verify details with the original source. Not investment advice. For informational purposes only.